GlassScriptPhysician profile
Stephen P Cleary
NPI 1386646743
$997.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $299 · 2021: $312.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $347.61 | 2019-2021 | |
| Allergan, INC. | $101.98 | 2019-2020 | |
| Coopersurgical, INC. | $86.10 | 2020-2021 | |
| Therapeuticsmd, INC. | $79.50 | 2019-2020 | |
| Exeltis, USA INC. | $55.93 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.44 | 2019 | |
| Mylan Pharmaceuticals INC. | $46.39 | 2021 | |
| Evofem Biosciences, INC. | $37.47 | 2021 | |
| Millicent US INC | $36.48 | 2019-2020 | |
| Avion Pharmaceuticals | $34.21 | 2019-2021 | |
| Covidien LP | $32.25 | 2019 | |
| Merck Sharp & Dohme LLC | $27.91 | 2019 | |
| Agile Therapeutics, INC. | $20.61 | 2021 | |
| Medicem INC. | $18.08 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.32 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $11.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Cleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.